A knock-in mouse model of Huntington's disease Ki140CAG is characterized.
Behavioral tests, MRS and glutamate imaging reveal significant alterations in mice.
The glutamate distribution is mapped in vivo into the brain using gluCEST imaging.
GluCEST imaging is proposed as a potential biomarker of Huntington's disease.